Pub. L. 115-271, tit. III, subtit. B, ch. 7, sec. 3272 (as amended)

PURPOSE.

Year: 2025Length: 120 wordsOfficial source
SEC. 3272. [21 U.S.C. 827 note] PURPOSE. (a) In General.—The purpose of this chapter is to provide drug manufacturers and distributors with access to anonymized information through the Automated Reports and Consolidated Orders System to help drug manufacturers and distributors identify, report, and stop suspicious orders of opioids and reduce diversion rates. (b) Rule of Construction.—Nothing in this chapter should be construed to absolve a drug manufacturer, drug distributor, or other Drug Enforcement Administration registrant from the responsibility of the manufacturer, distributor, or other registrant to— (1) identify, stop, and report suspicious orders; or (2) maintain effective controls against diversion in accordance with section 303 of the Controlled Substances Act (21 U.S.C. 823) or any successor law or associated regulation.
Cross-references to the US Code
21 U.S.C. 827 note
Pub. L. 115-271, tit. III, subtit. B, ch. 7, sec. 3272 (as amended): PURPOSE. | Justis AI